Nuclear Medicine and Molecular Imaging
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.3 | Q2 | 51.2% | 0.482 | Q2 | 59.6% |
| 2024 | 2.7 | Q2 | 67.3% | 0.517 | Q2 | 63.3% |
| 2023 | 1.3 | Q3 | 32.5% | 0.340 | Q3 | 52.6% |
| 2022 | 1.3 | 25.6% | 0.386 | Q3 | 58.1% | |
| 2021 | — | 32.6% | 0.560 | Q2 | 70.7% | |
| 2020 | — | — | 0.534 | Q3 | 68.2% | |
| 2019 | — | — | 0.473 | Q3 | 65.8% | |
| 2018 | — | — | 0.435 | Q3 | 61.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1869-3474
ISSN
1869-3482
country
DEcoverage
2010-2026